Home » FDA Guidance: Development and Use of Risk Minimization Action Plans

FDA Guidance: Development and Use of Risk Minimization Action Plans

Overview:

This 27-page PDF document provides guidance to industry on the development, implementation, and evaluation of risk minimization action plans for prescription drug products, including biological drug products.

Author: U.S. Food and Drug Administration | File Size: 81 KB | File Type: PDF

Find more white papers on Process Operations, Quality Assurance Control

View all white papers »

More content on this topic:

  • Featured White Papers
  • White Papers by Topic
Process Operations
Automation & Control
Finishing & Packaging
Facilities & Support
Contract Services
Industry Developments